1. National Cancer Institute (2016) Surveillance, epidemiology and end results stat fact sheets: prostate cancer. National Cancer Institute.
http://seer.cancer.gov/statfacts/html/prost.html
. Accessed October 4, 2016
2. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250–1261. doi:
10.1056/NEJMoa074311
3. National Conprehensive Care Network (2016) NCCN Clinical Practice Guidelines in Oncology - Prostate Cancer (Version 3.2016).
https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf
. Accessed October 4, 2016
4. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177(6):2106–2131. doi:
10.1016/j.juro.2007.03.003
5. Wilt TJ, Shamliyan T, Taylor B, MacDonald R, Tacklind J, Rutks I, Koeneman K, Cho CS, Kane RL (2008) Comparative effectiveness of therapies for clinically localized prostate cancer. Agency for Healthcare Research and Quality (US); (Comparative Effectiveness Reviews, No. 13.) Available from:
https://www.ncbi.nlm.nih.gov/books/NBK43147/